Obstetric - Nursing Case Study

Pathophysiology

• Primary mechanism: Placental insufficiency—Occurs when the placenta fails to deliver adequate oxygen and nutrients to the fetus, often due to abnormal trophoblastic invasion or vascular remodeling, leading to fetal growth restriction and preeclampsia.

• Secondary mechanism: Hypercoagulability—Pregnancy induces a pro-thrombotic state due to increased coagulation factors and decreased fibrinolysis, heightening the risk of venous thromboembolism and placental abruption.

• Key complication: Eclampsia—Progression from preeclampsia characterized by seizures; results from endothelial dysfunction, vasospasm, and reduced cerebral perfusion, necessitating immediate intervention to prevent maternal and fetal morbidity.

Patient Profile

Demographics:

34-year-old female, high-stress corporate executive

History:

• Key past medical history: Gestational diabetes in previous pregnancies, history of preeclampsia, chronic hypertension, and thyroid disorder

• Current medications: Labetalol, Levothyroxine, Prenatal vitamins

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and decreased fetal movement

• Key symptoms: Persistent headache, visual disturbances, shortness of breath, and significant swelling in hands and feet

• Vital signs: Blood pressure 180/120 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, temperature 99.1°F, oxygen saturation 92% on room air

Section 1

Initial assessment reveals a rapidly deteriorating condition. The patient's abdomen is tender to palpation, with noticeable guarding suggestive of potential placental abruption. Fetal heart monitoring shows persistent late decelerations, indicating fetal distress. Despite supplemental oxygen administration, the patient's oxygen saturation remains low at 89%, and she exhibits labored breathing with accessory muscle use. Neurological assessment identifies brisk reflexes with clonus, raising concerns for imminent seizure activity. The patient is also experiencing worsening peripheral edema, particularly in the lower extremities, and her facial swelling has become more pronounced.

Laboratory results return with alarming findings: elevated liver enzymes (AST 120 U/L, ALT 130 U/L), low platelet count (90,000/mm³), and elevated serum creatinine (1.8 mg/dL), indicating potential HELLP syndrome, a severe form of preeclampsia. Urinalysis confirms significant proteinuria. Coagulation studies show a prolonged prothrombin time, and D-dimer levels are markedly elevated, suggesting a heightened risk of disseminated intravascular coagulation (DIC). Immediate obstetrician consultation is warranted due to the critical nature of these findings, underscoring the need for potential emergency delivery.

The patient's status shifts abruptly as she begins to exhibit tonic-clonic seizure activity, confirming the progression to eclampsia. Magnesium sulfate is administered as per protocol to prevent further seizures, but the patient's blood pressure remains dangerously high despite additional antihypertensive therapy. The interdisciplinary team convenes urgently to discuss the need for expedited cesarean delivery to prevent further maternal and fetal compromise, given the non-reassuring fetal heart pattern and the mother's unresponsive hypertensive crisis. The decision is made to proceed with an emergency cesarean section, balancing the risks of surgical intervention against the life-threatening complications of eclampsia and placental insufficiency.

Section 2

As the team prepares for the emergency cesarean section, the patient's condition continues to evolve. Despite the administration of magnesium sulfate, the patient begins to exhibit signs of respiratory depression, with a respiratory rate dropping to 8 breaths per minute and oxygen saturation plummeting to 82% on high-flow oxygen. Her skin appears cyanotic, and she shows signs of altered mental status, with a Glasgow Coma Scale score decreasing to 10. The anesthesiologist is called urgently to assess the need for intubation to secure the airway and ensure adequate oxygenation during the surgical procedure.

Simultaneously, new diagnostic imaging reveals further complications. An abdominal ultrasound indicates a sizable retroplacental clot, confirming a significant placental abruption and providing additional evidence for the severe compromise of placental blood flow. Fetal biophysical profile scores are critically low, with minimal fetal movements and absent breathing movements. The fetal heart rate maintains a pattern of persistent late decelerations, reinforcing the diagnosis of fetal distress and emphasizing the urgency of delivery.

As the team moves swiftly to the operating room, the patient's blood pressure remains critically elevated at 180/110 mmHg, despite maximum doses of intravenous labetalol and hydralazine. Additionally, laboratory tests reveal further deterioration in her hematological status, with platelets dropping to 75,000/mm³, and evidence of worsening coagulopathy emerges, including a further prolonged prothrombin time and a drop in fibrinogen levels. The interdisciplinary team remains acutely aware of the delicate balance between managing the mother's life-threatening eclampsia and coagulopathy while ensuring the safest possible outcome for the neonate amidst the complexity of placental abruption and fetal distress.

Section 3

As the surgical team prepares to commence the emergency cesarean section, the anesthesiologist makes a critical decision to proceed with rapid sequence intubation given the patient’s declining respiratory status. The patient is successfully intubated, and mechanical ventilation is initiated, stabilizing her oxygen saturation at 94%. Despite the temporary stabilization of respiratory parameters, the patient's cardiovascular status remains precarious. Her blood pressure, although slightly reduced to 170/105 mmHg with the administration of additional antihypertensive agents, continues to indicate severe hypertension, posing a significant risk for intracranial hemorrhage in the context of eclampsia.

Intraoperatively, the obstetric team encounters significant challenges. Upon delivery, the neonate is found to have an Apgar score of 3 at one minute, necessitating immediate resuscitation by the neonatal team. Concurrently, the surgical team addresses the extensive retroplacental clot, which measures approximately 800 mL in estimated blood loss. As the procedure progresses, the patient’s coagulopathy becomes more apparent, with ongoing oozing noted from the surgical site, necessitating the administration of fresh frozen plasma and cryoprecipitate in an attempt to correct the coagulation abnormalities. Blood products are transfused to manage the acute blood loss anemia, as the patient’s hemoglobin drops to 7 g/dL.

Amidst these interventions, the patient's condition reveals a new complication: her urine output has dramatically decreased to less than 10 mL/hr, raising concerns about acute kidney injury. This oliguria, coupled with her elevated creatinine levels, now at 2.5 mg/dL, suggests a potential renal compromise secondary to both the severe preeclamptic state and the volume shifts experienced during the acute hemorrhagic episode. The interdisciplinary team must now consider the implementation of renal protective strategies and continuous hemodynamic monitoring to prevent further deterioration of renal function while navigating the complex interplay of ongoing eclamptic management, coagulopathy correction, and post-operative recovery.

Section 4

As the surgical team continues to manage the critical intraoperative challenges, a significant change in the patient's status is observed. Despite aggressive management of her coagulopathy and acute blood loss anemia, the patient's blood pressure exhibits an alarming drop to 85/50 mmHg, accompanied by a heart rate increase to 130 beats per minute. This abrupt hemodynamic shift indicates the development of hypovolemic shock, prompting an immediate reassessment of her fluid status and the potential need for ongoing transfusions. The anesthesiologist, alongside the obstetric team, rapidly initiates additional fluid resuscitation with crystalloids and administers vasopressors to support her diminishing blood pressure. The patient's oxygen saturation remains stable at 94% under mechanical ventilation, but the new cardiovascular instability necessitates heightened vigilance and continuous monitoring.

In parallel, the nephrology team is consulted to address the ongoing concerns regarding the patient's renal function. With the persistent oliguria and elevated creatinine levels, the team considers the initiation of renal replacement therapy to prevent further renal damage and support her compromised kidney function. The decision to start continuous renal replacement therapy (CRRT) is made cautiously, weighing the risks of fluid shifts in the context of her precarious hemodynamic status. This intervention aims to provide renal support while the medical team works diligently to stabilize her systemic condition.

As these critical measures are implemented, the patient's status prompts the interdisciplinary team to anticipate potential complications, such as further electrolyte imbalances or the onset of disseminated intravascular coagulation (DIC). The patient's evolving condition underscores the need for meticulous coordination among the surgical, critical care, and nephrology teams, ensuring all aspects of her care are optimized to navigate the complex interplay of her acute and chronic medical issues. The next steps in her management will focus on achieving hemodynamic stability, effective renal support, and continued monitoring for any additional postoperative complications.

Section 5

As the interdisciplinary team continues to monitor the patient closely, a new set of diagnostic results provides critical insights into her evolving condition. Laboratory tests reveal a marked decrease in platelet count to 40,000/µL, alongside prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), suggestive of the onset of disseminated intravascular coagulation (DIC). Additionally, her fibrinogen levels have dropped below 100 mg/dL, further confirming the diagnosis. This development signals a significant shift in her clinical status, requiring immediate intervention to address the coagulation abnormalities and prevent further bleeding complications.

In response to these alarming laboratory findings, the hematology team is consulted to devise a targeted management strategy. They recommend the administration of fresh frozen plasma (FFP) and cryoprecipitate to replenish clotting factors and fibrinogen. Concurrently, the patient's renal function continues to be a concern, with serum creatinine levels rising to 3.2 mg/dL and persistent oliguria despite ongoing CRRT. The nephrology team proposes adjustments to the CRRT settings to optimize fluid removal and electrolyte balance, mindful of the patient's unstable hemodynamics.

As these interventions are implemented, the critical care team remains vigilant for any signs of further deterioration. The patient's blood pressure, heart rate, and oxygen saturation are monitored meticulously, with an emphasis on detecting any new complications early. This phase of her care emphasizes the need for precise clinical reasoning, as the team balances her complex coagulation and renal issues while striving to maintain hemodynamic stability. The next steps will focus on evaluating the effectiveness of the current interventions and preparing for potential cascading effects of the DIC, ensuring that all clinical decisions are grounded in a comprehensive understanding of her multifaceted medical challenges.